Freddy A. Jimenez - 03 Jun 2024 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Role
SVP & GENERAL COUNSEL
Signature
/s/ Sam Martin, attorney-in-fact for Freddy A. Jimenez
Issuer symbol
CLDX
Transactions as of
03 Jun 2024
Net transactions value
-$185,900
Form type
4
Filing time
05 Jun 2024, 16:04:58 UTC
Previous filing
15 Feb 2024
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLDX Common Stock Options Exercise $83,102 +8,006 +31% $10.38 33,930 03 Jun 2024 Direct
transaction CLDX Common Stock Sale $269,002 -8,006 -24% $33.60 25,924 03 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLDX Incentive Stock Option (Right to Buy) Options Exercise $0 -8,006 -22% $0.000000 27,994 03 Jun 2024 Common Stock 8,006 $10.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.